SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | -54.5% | 239 | 0.0% | 0.00% | – |
| Q2 2023 | $11 | +10.0% | 239 | 0.0% | 0.00% | – |
| Q1 2023 | $10 | +11.1% | 239 | 0.0% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 239 | +8.6% | 0.00% | – |
| Q3 2022 | $9,000 | +28.6% | 220 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | +16.7% | 220 | +27.9% | 0.00% | – |
| Q1 2022 | $6,000 | -14.3% | 172 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | -22.2% | 172 | -14.4% | 0.00% | – |
| Q3 2021 | $9,000 | +28.6% | 201 | +73.3% | 0.00% | – |
| Q2 2021 | $7,000 | -22.2% | 116 | 0.0% | 0.00% | – |
| Q1 2021 | $9,000 | +12.5% | 116 | +18.4% | 0.00% | – |
| Q4 2020 | $8,000 | -55.6% | 98 | -66.4% | 0.00% | – |
| Q3 2020 | $18,000 | +125.0% | 292 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | 0.0% | 292 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -97.0% | 292 | -92.2% | 0.00% | -100.0% |
| Q4 2019 | $269,000 | -43.7% | 3,723 | +9.3% | 0.00% | -50.0% |
| Q3 2019 | $478,000 | -29.9% | 3,405 | -8.6% | 0.00% | -33.3% |
| Q2 2019 | $682,000 | -0.1% | 3,725 | -13.2% | 0.01% | 0.0% |
| Q1 2019 | $683,000 | +2176.7% | 4,291 | +1284.2% | 0.01% | – |
| Q4 2018 | $30,000 | -6.2% | 310 | +34.8% | 0.00% | – |
| Q3 2018 | $32,000 | -11.1% | 230 | 0.0% | 0.00% | – |
| Q2 2018 | $36,000 | -2.7% | 230 | 0.0% | 0.00% | – |
| Q1 2018 | $37,000 | – | 230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |